Ultra-LEAF™ Purified anti-human CD28 Antibod
- 产品名称：
- Ultra-LEAF™ Purified anti-human CD28 Antibod
- 产品类别：
- 抗体
- 产品编号：
- 302933
- 产品应用：
- 302933
- Verified Reactivity
- Human, Cynomolgus, Rhesus
- Reported Reactivity
- Baboon, Capuchin Monkey, Chimpanzee, Pigtailed Macaque, Sooty Mangabey, Squirrel Monkey
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- 0.2 ?m filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxin level is <0.01 EU/?g of the protein (<0.001 ng/?g of the protein) as determined by the LAL test.
- Preparation
- The Ultra-LEAF? (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF? solution contains no preservative; handle under aseptic conditions.
- Application
-
FC - Quality tested
IHC-F, Costim, FA - Reported in the literature, not verified in house
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per million cells in 100 ?l volume or 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
The Ultra-LEAF? Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for highly sensitive assays.
- Application References
(PubMed link indicates BioLegend citation) -
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
- Nunes J, et al. 1993. Biochem. J. 293:835.
- Calea-Lauri J, et al. 1999. J. Immunol. 163:62.
- Tazi A, et al. 1999. J. Immunol. 163:3511. (IHC)
- Marti F, et al. 2001. J. Immunol. 166:197. (Costim)
- Jeong SH, et al. 2004. J. Virol. 78:6995. (Costim)
- Rivollier A, et al. 2004. Blood 104:4029. (Costim)
- Scharschmidt E, et al. 2004. Mol. Cell Biol. 24:3860. (Costim)
- Sheng W, et al. 2007.Elsevier 580:6819. PubMed
- Mitsuhashi M. 2007. Clin Chem.53:148. PubMed
- Ye Z, et al. 2008. Infect. Immun. 76:2541. PubMed
- Magatti M, et al. 2008. Stem Cells 26:182. (FA) PubMed
- Yoshino N, et al. 2008. Exp. Anim. (Tokyo) 49:97. (FC)
- Berg M, et al. 2008. J Leukoc Biol. 83:853. (IP) PubMed
- Rout N, et al. 2010. PLoS One 5:e9787. (FC)
- Leonard JA, et al. 2011. J. Virol. 85:6867. PubMed
- Nomura T, et al. 2012. J. Virol. 86:6481. PubMed
- Product Citations
-
- Zheng G, et al. 2021. Signal Transduct Target Ther. 6:236. PubMed
- Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
- Sungur CM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
- Pozzetto B, et al. 2021. Nature. 600:701. PubMed
- Liu Y, et al. 2021. Immunol Cell Biol. 99:697. PubMed
- Yuan X, et al. 2022. J Extracell Vesicles. 11:e12235. PubMed
- Wu SY, et al. 2021. J Immunother Cancer. 9: . PubMed
- Amiad-Pavlov D, et al. 2021. Sci Adv. 7: . PubMed
- Romero-Olmedo AJ, et al. 2022. Nat Microbiol. 7:195. PubMed
- Nicolas P, et al. 2022. J Exp Med. 219:. PubMed
- Yi K, et al. 2022. Front Immunol. 12:802795. PubMed
- Bellini N, et al. 2022. iScience. 25:105234. PubMed
- Wang C, et al. 2021. Cell Stem Cell. . PubMed
- Zhao J, et al. 2021. Front Immunol. 12:658420. PubMed
- Kwon M, et al. 2020. Clin Cancer Res. 1644:26. PubMed
- Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
- Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
- Naaber P, et al. 2022. Cell Rep Med. 3:100716. PubMed
- Wang J, et al. 2022. Nat Commun. 13:6866. PubMed
- Schofield DJ, et al. 2021. MAbs. 13:1857100. PubMed
- Blewett M, et al. 2016. Sci Transl Med. 8: 356ra119. PubMed
- Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
- Jung Y, et al. 2021. Nat Commun. 12:3872. PubMed
- Lerrer S, et al. 2021. iScience. 24:103020. PubMed
- Camviel N, et al. 2022. J Immunother Cancer. 10:. PubMed
- Smith CM, et al. 2021. Biochem J. 478:3331. PubMed
- Chan W, et al. 2021. Immunohorizons. 5:117. PubMed
- Saragovi A, et al. 2020. Elife. 9:00. PubMed
- Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
- Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
- Fuseini H, et al. 2022. Front Immunol. 12:796898. PubMed
- Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
- Lin M, et al. 2015. Immunol Lett. 165:26. PubMed
- Han K, et al. 2021. Nat Metab. 3:318. PubMed
- Kinloch NN, et al. 2021. Nat Commun. 12:165. PubMed
- Sadik A, et al. 2020. Cell. 1252:182. PubMed
- Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
- Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
- Collins DR, et al. 2021. Immunity. 54:2372. PubMed
- McBrien JB, et al. 2020. Nature. 578:154. PubMed
- Sun T, et al. 2019. Haematologica. 105:661. PubMed
- Texler B, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:383. PubMed
- Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
- Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
- Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
- Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
- Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
- Sabag B, et al. 2022. Cancers (Basel). 14:. PubMed
- Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
- Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
- Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
- Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
- Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
- Niu M, et al. 2021. Cell Reports. 36(8):109611. PubMed
- Kotanides H, et al. 2020. Mol Cancer Ther. 988:19. PubMed
- Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
- Davis-Marcisak EF, et al. 2021. Genome Med. 13:129. PubMed
- RRID
- AB_11150591 (BioLegend Cat. No. 302933) AB_11148949 (BioLegend Cat. No. 302934) AB_2616667 (BioLegend Cat. No. 302943) AB_2616668 (BioLegend Cat. No. 302944) AB_2800748 (BioLegend Cat. No. 302959) AB_2800749 (BioLegend Cat. No. 302960)
- Structure
- Ig superfamily, type I transmembrane glycoprotein, homodimer, 44 kD
- Distribution
-
Mature T cells, thymocytes, NK cell subsets, plasma cells, EBV-positive B cells
- Function
- T cell costimulation
- Ligand/Receptor
- CD80, CD86
- Cell Type
- B cells, NK cells, Plasma cells, T cells, Thymocytes, Tregs
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
2. June CH, et al. 1994. Immunol. Today 15:321.
3. Linskey PS, et al. 1993. Annu. Rev. Immunol. 11:191.
- Gene ID
- 940 View all products for this Gene ID
- UniProt
- View information about CD28 on UniProt.org
